AI channel feed

FDA+ roundup: Agency re­opens AI dis­cus­sion pa­per for com­ments amid two-day work­shop

2 days ago
Pharma
FDA+

Ex­clu­sive: Deep­Mind’s Demis Has­s­abis un­veils his vi­sion for Iso­mor­phic and AI’s fu­ture in biotech

3 days ago
People

Benev­o­len­tAI, Ex­sci­en­tia on the come­back trail af­ter se­cur­ing sep­a­rate AI drug dis­cov­ery deals with Mer­ck KGaA

Last week
Deals

Al­phaFold, meet Al­phaMis­sense: Google Deep­Mind's AI suc­ces­sor pre­dicts how 71M mu­ta­tions cause dis­ease

Last week

Ab­cam founder Jonathan Mil­ner op­pos­es Dana­her buy­out; First Wave tries to find new life in Sanofi drug

3 weeks ago
News Briefing

Flag­ship’s AI uni­corn Gen­er­ate rais­es $273M Se­ries C, as first drug in 17-pro­gram pipeline en­ters the clin­ic

3 weeks ago
Financing

An­dreessen Horowitz-backed start­up lands $200M for AI-based drug dis­cov­ery

Last month
Financing
R&D

Phar­ma gi­ants tout AI tools as high pri­or­i­ty in half-year earn­ings re­ports

2 months ago
Pharma

EMA to drug de­vel­op­ers on AI: Car­ry out thor­ough risk as­sess­ments

2 months ago
Pharma

Causaly, an AI start­up help­ing with pre­clin­i­cal dis­cov­ery, nabs $60M from VCs and for­mer J&J chief Alex Gorsky

2 months ago
Financing
Startups

Der­ma­vant taps AI for ‘white-glove’ web­site ser­vice for Vta­ma pso­ri­a­sis med

2 months ago
Pharma
Marketing

Tril­lion-dol­lar part­ner: Re­cur­sion rais­es $50M from Nvidia, stock sky­rock­ets

2 months ago
Financing

Ex­clu­sive: The se­cret to de­sign­ing pro­tein drugs with AI? Gen­er­ate be­lieves it's cryo-EM at un­prece­dent­ed scale

3 months ago
R&D
Discovery

Mod­er­na 'laser-fo­cused' on AI, from clin­i­cal de­vel­op­ment to mar­ket­ing: #Can­nes­Lions2023

3 months ago
Pharma
Marketing

Ex­clu­sive: With $8M, neu­ro start­up Mod­u­lo Bio emerges to test small mol­e­cules for ALS, de­men­tia in CEO’s per­son­al mis­sion

4 months ago
Financing
Startups

XtalPi inks $250M pact with Lil­ly af­ter Pfiz­er suc­cess

4 months ago
Deals
China

Vee­va adds gen­er­a­tive AI tool for phar­ma reps as it rolls out new soft­ware plat­form

4 months ago
Pharma
Marketing

Boehringer and Lon­za ques­tion the fu­ture of FDA's reg­u­la­tion of AI in man­u­fac­tur­ing

5 months ago
Pharma
Manufacturing

Durham start­up rais­es Se­ries A to tack­le un­drug­gable pro­teins, in­clud­ing can­cer bad­die Myc, with gen­er­a­tive AI

5 months ago
Financing
Startups

MD An­der­son, Flag­ship start­up part­ner to de­sign and test can­cer drugs made with gen­er­a­tive AI

5 months ago
Deals

Mod­er­na, IBM turn to quan­tum com­put­ing in hunt for new mR­NA med­i­cines

5 months ago
Deals

AI tools don't equal guar­an­teed drug suc­cess as Benev­o­len­tAI flops der­mati­tis test

5 months ago
R&D

Chat­G­PT with phar­ma da­ta de­buts for med­ical meet­ings, be­gin­ning with AACR

6 months ago
Pharma
Marketing

Sy­neos Health inks deal with Mi­crosoft to use AI tech­nol­o­gy

6 months ago
Deals
Manufacturing
1234 Next page Last page
A service from the Financial Times